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Cigarette smoking is associated with infl ammatory bowel diseases (IBD), but with 
a remarkable opposite eff ect in Crohn’s disease (CD) and ulcerative colitis (UC). 
Smoking aggravates CD and ameliorates UC. Here, we investigated the smoke-
induced signaling pathways in order to explain this dichotomy. 
METHODS
Intestinal epithelial cells (DLD-1) and T-cells (Jurkat) were exposed to cigarette 
smoke extract (CSE) and cellular changes in signaling pathways were identifi ed 
using kinome profi ling. Cells were exposed to infl ammatory triggers (anti-Fas, 
cytokines, menadione) in presence or absence of CSE, nicotine, acrolein or carbon 
monoxide-releasing molecules (CORMs). Apoptosis was quantifi ed by caspase-3 
assays and PARP cleavage. Contribution of apoptotic pathways was studied using 
specifi c inhibitors. Necrosis and cell viability were determined by Sytox Green 
nuclear staining and WST-1 assays, respectively. 
RESULTS
Kinome analyses revealed that the canonical apoptotic pathway was inhibited by 
CSE, while multiple survival pathways were stimulated simultaneously, including 
AMPK, PI3K and ERK1/2. CSE dose-dependently (from 0-20% CSE) suppressed 
caspase-3 activity provoked by anti-Fas, cytokine mixture or menadione in both 
DLD-1 and Jurkat cells with a concomitant increase in cellular metabolic activity. CSE 
concentrations above 30% induced necrosis. Inhibition of individual CSE-activated 
anti-apoptotic signaling partially reversed CSE eff ects on survival. All tested cigarette 
smoke compounds showed anti-apoptotic eff ects, with CORMS being the most 
potent. 
CONCLUSION
Smoke components exert multiple anti-apoptotic eff ects in epithelial cells and 
T-lymphocytes, which may aggravate CD that is characterized by apoptosis-resistant 
T-cells. Conversely, it may prevent excessive damage to the colonic epithelium and 
thereby ameliorate UC. 
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Crohn’s disease (CD) and ulcerative colitis (UC) are the two major types of 
infl ammatory bowel disease (IBD). CD is characterized by transmural discontinuous 
infl ammation with granuloma and may aff ect the whole gastrointestinal tract. UC 
is characterized by a superfi cial continuous infl ammation of the mucosa of the 
colon ascending from the rectum1. Both CD and UC develop as a consequence of 
a complex interplay between genetic and environmental factors. Recent genome-
wide association studies have provided a comprehensive map of genes that are 
linked to the propensity to these diseases2. Though instrumental for defi ning the 
cellular processes that may promote CD or UC, genetic predisposition only explains 
about 20% of CD and <10% of UC disease development2,3. This implies that IBD is 
primarily caused by environmental factors. The most prominent environmental 
factor that is implicated in the development of IBD is cigarette smoke and was fi rst 
documented in the early 1980s, with smokers being overrepresented in CD and 
underrepresented in UC compared to the healthy control population4,5. Since then, 
many studies have confi rmed that smoking aggravates CD and ameliorates UC. 
Smoking is associated with a higher prevalence of ileal disease in CD, more complex 
disease, increased need for steroids and immunosuppressive therapy as well as 
poorer response to therapy with infl iximab6,7. In contrast, smoking is associated with 
less hospitalizations in UC and decreased need for steroids and surgery7,8. Recently, 
we found that also passive smoking is detrimental for CD patients and that active 
smoking showed dose-dependent benefi cial eff ects in UC8.
How smoking modulates disease course and therapeutic outcome in IBD is still 
unclear. Several potential mechanisms, including smoke-provoked alterations in 
mucosal immune responses, modifi cations in intestinal mediators and cytokines 
and modulation of gut permeability have been proposed6,9, but none of these off ers 
a satisfying explanation for the dichotomal eff ects of smoking on CD and UC. The 
intestinal tract is composed of several barriers to prevent pathogenic invasion. 
However, bacteria and dietary antigens constantly pass the epithelium leading to a 
state of controlled infl ammation. Disruption of the barrier allows luminal pathogens 
to pass the epithelium and ongoing exposure of pathogens triggers the immune 
system and causes infl ammation of the colon leading to epithelial damage. To limit 
infl ammation to a subclinical state, a delicate balance between continuous cell 
replacement and repair of the epithelium is required. Regulatory mechanisms are 
essential for eliminating damaged cells during tissue remodeling and infl ammation, 
processes that appear to be modulated by cigarette smoke with opposite outcomes 





in CD and UC. Therefore, we set out to identify the regulatory mechanisms provoked 
by cigarette smoke and studied their putative role in the dichotomal eff ects on the 
two main forms of IBD. Defi ning the cigarette smoke-induced cellular (dys)functions 
will help to understand disease progression in smoking and non-smoking patients 
with CD or UC and may unveil novel therapeutic targets for these diseases.
MATERIALS AND METHODS
CELL LINES AND CULTURE CONDITIONS
Human colonic epithelial cell lines (DLD-1, SW480, HCT116, Caco-2) and 
T-lymphocyte cell lines (Jurkat, MOLT-4) were cultured in T75 fl asks (Greiner bio-one, 
Alphen aan den Rijn, The Netherlands) as described previously10. Cells were exposed 
to various apoptotic stimuli in presence or absence of diff erent concentrations 
cigarette smoke extract (CSE; 0-100% v/v) as specifi ed in the result section. CSE 
was prepared as described11 by passing smoke from 2 standard 3R4F research 
cigarettes (Lexington, KY, USA) through 25 ml culture medium, which was defi ned 
as 100% CSE. Death receptor-mediated apoptosis was induced by anti-Fas (1 µg/
ml)12 or cytokine mixture (CM; consisting of TNF-α, IFN-γ and IL-1β, 10 ng/ml each)10. 
Oxidative stress-mediated apoptosis was induced by the superoxide anion donor 
menadione (50 mmol/l)13. Anti-Fas-induced caspase-3 activity is maximal at 9 and 
3 hours in DLD-1 and Jurkat cells, respectively12. For CM- and menadione-induced 
apoptosis, caspase-3 activity peaks at 16 hours in DLD-1 cells. Therefore, these time-
points were chosen to study the eff ect of CSE. 
In addition, cells were exposed to a water-soluble fraction of CSE, which was 
obtained by a “water pipe” setting. Smoke from 2 cigarettes was fi rst passed through 
25 ml HBSS-buff er (= 100% water pipe medium) and subsequently led through 25 
ml culture medium (= 100% CSE after water pipe medium). Furthermore, cells were 
exposed to various pure compounds of cigarette smoke, e.g. nicotine, acrolein and 
carbon monoxide (CO), to study their eff ect on anti-Fas-, CM-, or menadione-induced 
apoptosis. Nicotine (#N5260; Sigma-Aldrich, MO, USA) was added at concentrations 
0.1-10 µM. Acrolein (#A1679; Sigma) was used at concentrations of 25-100 µM. CO 
was either diff used through 25 ml medium, similar as preparing CSE, or by adding 
CO-releasing molecule-2 (CORM-2, tricarbonyldichlororuthenium II dimer, #288144; 
Sigma) at concentrations of 50-200 µM. In parallel, cells were incubated with 
inactivated (incubated at 37°C for 24 hour and saturated with nitrogen for 1 hour 
just before use) CORM-2. 
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KINOME PROFILING AND DATA ACQUISITION
The peptide array data analysis was done as described earlier14. Spot density and 
background from three technical replicates of each individual experimental sample 
were analyzed using Scanalyze (http://rana.lbl.gov/EisenSoftware). For each peptide 
the average and standard deviation of phosphorylation was determined and 
plotted in an amplitude-based hierarchical fashion. Background phosphorylation 
of the array was determined from the exponent describing the amplitude behavior 
of the 500 least phosphorylated peptides (which are assumed not to contain 
phosphorylation derived from a relevant biological signal). Peptides of which the 
average phosphorylation minus 1.96 times the standard deviation was higher 
than background were considered to represent true phosphorylation events 
(P<0.05). Peptide sets that showed statistically signifi cant changes compared to 
the background were subsequently subjected to elective Markov analysis and the 
resulting binary values were also analyzed in cohorts of peptides representing 
a read out for the same signal transduction element, collapsing results towards 
human interpretable format. Signifi cance analysis was performed using a minimal 
modifi cation for the algorithm originally developed for microarray analysis (www-
stat.stanford.edu/~tibs/SAM/) and was essentially done as described earlier15. 
PROTEIN EXTRACTION AND CONCENTRATION DETERMINATION
Cells were harvested in lysis buff er (25 mmol/l HEPES, 2 mmol/l EDTA, 150 mmol/l 
KAc, 0.1% NP40, 10 mmol/l NaF, 1 mmol/l PMSF, 1 mmol/l DTT, aprotinine, leupeptide 
and prostatine (each 1 µg/ml) pH 7.2) followed by four cycles of freezing (liquid 
nitrogen) and thawing (37°C). Lysates were centrifuged (10 min, 12.500xg, RT) and 
supernatant was stored at -80°C until use. Protein concentrations were determined 
using the BioRad DC protein assay (BioRad, CA, USA). Absorbance was measured at 
750 nm on an EL800 universal microplate reader (Bio-Tek instruments, VT, USA). 
WESTERN BLOTTING
Total protein extracts (20 µg) from control and treated cells were separated on 
10% sodium dodecyl sulphate polyacrylamide (SDS-PAGE) gels and transferred 
to nitrocellulose membrane (GE Healthcare Europe, Diegem, Belgium). After 
blocking with 5% skim milk, membranes were probed with primary antibodies 
(Supplementary table S1). The target proteins were visualized using an enhanced 
chemiluminescence SuperSignal West Dura detection system (#34076; Pierce, IL, 
USA). GAPDH (#CB1001; Calbiochem, CA, USA) was used as loading control.





QUANTIFICATION OF APOPTOTIC AND NECROTIC CELL DEATH 
Caspase-3 activity in 20 µg total cellular protein was measured as described 
previously16 using an FL600 microplate fl uorescence reader (Bio-Tek instruments) 
with excitation and emission set at 380 and 460 nm, respectively. To detect necrotic 
cell death (leaky plasma membrane), cells were incubated for 15 min with sytox 
green nucleic acid stain (Molecular Probes, OR, USA), as previously described13.
METABOLIC ACTIVITY
Metabolic activity of cells was determined using WST-1 reagent following the 
instructions of the manufacturer (Roche, CA, USA). Cells exposed to 5 mmol/l H2O2 
were used as a control for complete suppression of metabolic activity.
INHIBITION OF PHOSPHORYLATION
To determine the contribution of the survival/proliferation PI3K/Akt and/or 
autophagy/AMPK pathways to CSE-mediated protection of DLD-1 and Jurkat cells to 
apoptosis, we used the PI3K inhibitor LY294002 (50 µM for DLD-1, 25 µM for Jurkat), 
the ERK1/2 inhibitor U01260 (10 µM) and the AMPK inhibitor 5-iodotubercidin (0.1 
µM) in the absence or presence of CSE and/or anti-Fas. Cells were pre-treated with 
the inhibitors for 30 min.
STATISTICAL ANALYSIS
Data are expressed as the means ± SD of at least 3 independent experiments 
that were each performed in duplicate. One way analysis of variance (ANOVA) in 
combination with a Bonferroni correction was used to determine the statistical 
signifi cance of the diff erences between groups. A P value of <0.05 was considered 
statistically signifi cant. 
RESULTS 
DISSECTION OF THE MOLECULAR PATHWAYS MODULATED BY CIGARETTE SMOKE
First, we determined the eff ect of various concentrations cigarette smoke-saturated 
medium (e.g. cigarette smoke extract; CSE) on cell viability and the metabolic activity 
of DLD-1 cells (model for human intestinal epithelial cells) and Jurkat cells (model 
for human T-lymphocytes) (Figure 1). Concentrations up to 20% CSE did not cause 
signifi cant levels of necrosis in either cell type (Figure 1A). In fact, these conditions 
signifi cantly enhanced the metabolic activity of both cell types compared to 
untreated control cells (Figure 1B and C, for DLD-1 and Jurkat, respectively). High 
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concentrations of 50 and 100% CSE strongly reduced the metabolic activity of DLD-1 
cells and Jurkat cells and causes massive necrosis.
DISSECTION OF THE CELL SIGNALING PATHWAYS MODULATED BY CIGARETTE SMOKE
To identify possible molecular signaling pathways that are modulated by CSE, 
we resorted to kinome profi ling, an unbiased approach allowing the generation 
of comprehensive description of cellular signaling without the need of a priori 
assumptions as to the pathways aff ected by smoke. DLD-1 and Jurkat cells incubated 
with or without 20% CSE for 30 min were used for this analysis. The data were subjected 
to Markov analysis and the results reveal the complement of kinase changes upon 
CSE challenge. For 20% CSE 141 DLD-1 and 184 Jurkat phosphorylated substrates 





Figure 1. Dose-dependent eﬀ ect of CSE on cell viability and metabolic activity in DLD-1 and Jurkat 
cells. DLD-1 and Jurkat cells were exposed to increasing concentrations CSE for 16 or 3 hours, respectively. 
(A) Necrotic cell death was evaluated by Sytox green nuclear staining. Fluorescent images were taken at a 
magnifi cation of 40x. (B) The metabolic activity was quantifi ed using the WST-1 assay. 5 mmol/l H2O2 was 
used as positive control for inducing necrosis and full suppression of metabolic activity. Data represent 
means ± SD of at least three independent experiments. *P<0.05 vs. control of corresponding bars.





were detected (Supplementary Table S2A and B). A schematic representation of all 
diff erentially phosphorylated peptides can be found in Supplementary Figure S1. 
Overall, analyses revealed that CSE activates signals associated with inhibition of 
ligand-induced apoptosis (Figure 2), while cell proliferation pathways and autophagy 
were induced (Supplementary Figure S1). Individual proteins were analyzed by 
Western blotting and in most cases confi rmed the kinome analysis (Figure 3A 
and B, for DLD-1 and Jurkat cells, respectively), with some exceptions described 
below. Exposure of DLD-1 cells to 20% CSE increased the phosphorylation of STAT5, 
ERK1/2, Bad and protein levels of Bcl-XL (anti-apoptotic/pro-survival); increased 
phosphorylation of Akt, GSK3β and protein levels of cyclin D1 (pro-proliferation); 
and increased phosphorylation of AMPK and lipidation of LC3 (anti-apoptotic/pro-
Figure 2. Provisional signal transduction schemes - impression of kinome profi ling results. Paired 
cultures of DLD-1 cells and Jurkat cells were challenged with vehicle or 20% CSE followed analysis for 
kinase activity using peptide arrays. Results were collapsed on selective signal transduction categories 
and expressed in gray scale (representing the number of peptides phosphorylated as a fraction of all 
peptides in that category). Vehicle and CSE eff ects were contrasted. The results provide an overview of 
anti-apoptosis and pro-survival pathways active in DLD-1 cells and Jurkat cells and the eff ects of CSE 
thereon.
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Figure 3. Cell signaling pathways activated by CSE. DLD-1 and Jurkat cells were exposed for 30 min 
to 0% and 20% CSE and expression of phosphorylated forms of Src, STAT5, ERK1/2, Bad, Akt, GSK3β and 
AMPK, and protein expression of Bcl-XL, cyclin D1 and LC3 in DLD-1 (A) and Jurkat (B) cells was analyzed 
by Western blotting. GAPDH was used as loading control.
autophagy) (Figure 3A). The CSE-induced phosphorylation of AMPK in DLD-1 was 
not detected in the kinome analysis, possibly by low basal levels in control cells 
and/or the fact that only 1 AMPK target peptide was phosphorylated in the kinome 
array in those cells. In Jurkat cells, 20% CSE decreased phosphorylation of ERK1/2, 
but increased protein levels of Bcl-XL (anti-apoptotic/pro-survival); increased 
phosphorylation of Akt, GSK3β and protein levels of cyclin D1 (pro-proliferation); 
and increased phosphorylation of AMPK (anti-apoptotic/pro-autophagy) (Figure 
3B). Together, these data provide novel data on the eff ects of cigarette smoke in 
two diff erent in vitro models with relevance for IBD and demonstrate that the main 
action of cigarette smoke is activation of anti-apoptotic and pro-survival pathways.
SMOKE EXERTS CYTOPROTECTIVE EFFECTS UPON PRO-APOPTOTIC STIMULATION
Next, we analyzed whether the CSE-induced anti-apoptotic/pro-survival pathways 
translate into functional consequences with respect to protection against pro-
apoptotic triggers, including anti-Fas, CM and menadione. Anti-Fas-induced 
caspase-3 activity was dose-dependently inhibited by CSE (10-20%) in both DLD-





1 (Figure 4A) and Jurkat cells (Figure 4B). Similarly, CM- and menadione-induced 
caspase-3 activity was dose-dependently inhibited by CSE (5-20%) in DLD-1 
cells (Figure 4A). Jurkat cells were not sensitive for CM- and menadione-induced 
apoptosis. In line with the reduction in caspase-3 activity, CSE also reduced the level 
of PARP cleavage (marker for late apoptosis) induced by anti-Fas, CM or menadione 
in DLD-1 and Jurkat cells (only for anti-Fas for the latter) (Figure 4C and D). The CSE 
inhibitory eff ects were most pronounced for menadione-induced apoptosis. CSE 
alone did not induce caspase-3 activity. Similar results were obtained when these 
experiments were performed with other intestinal (HCT116, SW480, Caco-2) or 
lymphocyte (MOLT-4) cell lines (Supplementary Figure S2 A-D). 
DISSECTION OF THE RELATIVE IMPORTANCE OF CSE-INDUCED SIGNALING PATHWAYS IN CYTOPROTECTION 
Several pro-apoptotic pathways are simultaneously suppressed by CSE. In order to 
determine which pathways contribute to the anti-apoptotic eff ect of CSE, we blocked 
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Figure 4. CSE inhibits death receptor- and oxidative stress-induced apoptosis in DLD-1 and Jurkats 
cells. (A) Caspase-3 activity in total extracts of DLD-1 cells exposed to anti-Fas, CM or menadione in 
combination with increasing concentrations CSE. (B) Caspase-3 activity in total extracts of Jurkat cells 
exposed to anti-Fas in combination with increasing concentrations CSE. Maximal caspase-3 activity is 
presented as 100%. Data represent means ± SD of at least three independent experiments. *P<0.05 vs. 
control. (C,D) Western blot analysis of PARP showing that CSE inhibits anti-Fas-induced cleavage to the 89 
kDa form in DLD-1 (C) and Jurkat (D) cells. GAPDH was used as loading control.
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Figure 5. The anti-apoptotic eﬀ ect of CSE is not solely dependent of the AMPK, PI3K or ERK1/2 
pathway. DLD-1 and Jurkat cells were exposed to anti-Fas and CSE with or without (A) the AMPK inhibitor 
5’-iodotubercidin, (B) the PI3-kinase inhibitor LY294002 (C) the ERK1/2 inhibitor U01260. Caspase-3 
activity was presented as fold-change compared to control; control values were set at one. Data represent 
means ± SD of at least three independent experiments. *P<0.05 vs. anti-Fas treated cells, #P<0.05 vs. cells 
co-treated with anti-Fas and inhibitor, $P<0.05 vs. anti-Fas/CSE co-treated cells.
or the ERK1/2 pathway (by U01260) in anti-Fas/CSE co-treated DLD-1 and Jurkat cells 
(Figure 5). The CSE-induced reduction in caspase-3 activity in anti-Fas-treated Jurkat 
cells was signifi cantly reversed by the AMPK-inhibitor (Figure 5A). A similar trend 
was observed for DLD-1 cells, but was not statistically signifi cant. Inhibition of the 
PI3K and ERK1/2 pathway signifi cantly increased the caspase-3 activity in anti-Fas/
CSE co-treated cells (Figure 5B and C), however, this was also observed in anti-Fas 
treated cells. This implies that the PI3K or ERK1/2 pathways are already activated 
by anti-Fas and a potential additive eff ect of CSE cannot with certainty be deduced 
from these inhibitor experiments (Figure 5B and C). Taken together, these data show 
that the anti-apoptotic eff ect of CSE is mediated through multiple pathways and 
that inhibition of the AMPK pathway may provide a degree of specifi city between 
the epithelial compartment and T-cell compartment respectively. The putative 








Figure 6. Nicotine, CO and acrolein contribute to the anti-apoptotic eﬀ ects of cigarette smoke. 
Caspase-3 activity in DLD-1 cells after co-treatment with anti-Fas, CM or menadione and increasing 
concentrations of (A) the water-soluble fraction of CSE, (B) Nicotine (0-10 µM), (C) 100% CO-saturated 
medium, (D) CORM-2 or (E) acrolein (0-100 µM). Data represent means ± SD of at least three independent 
experiments. *P<0.05 vs. control, #P<0.05 vs. CORM-treated control bars.
involvement of the ERK1/2 or the PI3K pathway in the CSE-mediated anti-apoptotic 
eff ect cannot be established, since those pathways are already activated by anti-Fas.
EFFECTS OF SMOKE CONSTITUENTS
Finally, we aimed to determine which compounds in cigarette smoke contribute to 
the anti-apoptotic eff ect of CSE. In a setup that can be compared to a “water pipe”, we 
fi rst passed the smoke of 2 research cigarettes through 25 ml of water, after which 
it was passed through 25 ml medium. The anti-apoptotic eff ect completely shifted 
to the “water-trap” indicating that the protective compound(s) were eﬃ  ciently and 
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completely solubilized in water (Figure 6A). Cigarette smoke compounds that are 
highly water-soluble are nicotine and acrolein, but may also include gases like CO. 
These compounds were further evaluated for their anti-apoptotic properties on 
anti-Fas-treated DLD-1 cells. Nicotine decreased anti-Fas induced caspase-3 activity 
with 31 ± 9.9% (10 µM; Figure 6B). Incubation with CO-saturated medium yielded 
a reduction of 46 ± 2.5% (Figure 6C). CM- and menadione-induced apoptosis were 
also inhibited by CO-saturated medium. CORM2 and acrolein dose-dependently 
decreased caspase-3 activity up to 59 ± 1.9% (200 µM; Figure 6D) and 69 ± 3.5% (100 
µM; Figure 6E), respectively. Tested concentrations had no eff ect on the metabolic 
activity of DLD-1 cells, nor did it induced necrosis (data not shown). We conclude 
that cigarette smoke contains multiple water-soluble components exhibiting a 
cytoprotective action on intestinal epithelial cells and T-lymphocytes, possibly 
explaining the multitude of cytoprotective pathways induced.
DISCUSSION
In this study, we show that cigarette smoke induces phosphorylation of kinases that 
are involved in anti-apoptotic (STAT5B/ERK1/2) and pro-survival pathways (AMPK/
Akt/PI3K) in intestinal epithelial cells and T-lymphocytes. This was accompanied 
by enhanced levels of anti-apoptotic Bcl-XL/Bcl-2 proteins, pro-survival proteins 
GSK3β, cyclin D1 and lipidation of the autophagy marker LC3. Cigarette smoke 
enhanced the metabolic activity of intestinal epithelial cells and T-lymphocytes and 
suppressed anti-Fas-, cytokine- and oxidative stress-induced apoptosis. The smoke 
components nicotine, CO and acrolein all suppressed apoptosis to variable degrees 
and inhibition of single pro-survival kinase pathways did not block the protective 
eff ect of cigarette smoke. Our data show that cigarette smoke induces a plethora 
of pro-survival pathways and protects intestinal epithelial cells and T-lymphocytes 
against infl ammation-induced apoptosis. Cigarette smoke may aggravate CD by 
enhancing the resistance of T-lymphocytes to apoptosis, while it may ameliorate UC 
by preventing excessive damage to the intestinal epithelial layer (Figure 7).
The kinome profi ling combined with the Western blot analysis of protein 
phosphorylation revealed a smoke-dependent stimulation of pro-survival pathways 
(AMPK/Akt/PI3K and GSK3β/cyclin D1/LC3) and anti-apoptotic pathways (STAT5B/
ERK1/2 and Bcl-XL/Bcl-2). These observations correspond well to previous studies, 
where eff ects of cigarette smoke were investigated in COPD and lung cancer using 
micro array analysis and/or proteomic approaches17,18. Similar kinase pathways were 
found to be aff ected by smoke, supporting a common role by which cigarette smoke 





Figure 7. Proposed model for the dichotomal eﬀ ects of cigarette smoke on Crohn’s disease and 
ulcerative colitis explained by inhibition of apoptosis. Upper panel: Normal colon with mild apoptosis 
activity and mixed infi ltrate restricted to the top of villi. Crypt architecture is preserved. The crypts 
are parallel to each other and extend from the luminal surface to the muscularis mucosae. Upper left 
panel: Ulcerative colitis with high apoptosis rates in the epithelium. Severe diff use crypt atrophy and 
diff use chronic infl ammation with mixed infi ltrate. Crypt distortion includes crypt branching and 
loss of parallelism. Lower left panel: Crohn’s disease with diff use transmucosal chronic infl ammation 
including lamina propria infi ltrate, mainly T-lymphocytes. Abnormal crypt architecture. Upper right 
panel: Ulcerative colitis after smoking with less apoptosis activity in the epithelium. Restoration of crypt 
architecture and less mucosal infi ltrate. Lower right panel: Crohn’s disease after smoking with severe 
transmucosal chronic infl ammation and T-lymphocyte infi ltrate. Less apoptosis of T-lymphocytes shifting 
toward excessive proliferation.
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acts throughout the human body. Cigarette smoke seems to act, at least partly, 
through the AMPK pathway as AMPK inhibition reversed the CSE-cytoprotective 
eff ect in Jurkat cells and a similar trend was observed for DLD-1 cells. A potential 
role of the PI3K and/or ERK pathway in the anti-apoptotic eff ect of smoke under 
infl ammatory conditions remains obscure, as these are already activated by anti-Fas. 
However, key factors in these pathways are activated by CSE in the absence of anti-
Fas and therefore may provide a basal protection to apoptosis.  
Maintenance of the colonic epithelium is the result of a delicate balance between 
cell proliferation at the base and cell death (apoptosis) at the surface epithelium. 
Apoptosis must therefore be highly regulated and minor perpetuations in epithelial 
apoptosis rates may disturb the epithelial barrier and allow luminal pathogens to 
pass the epithelium. The ongoing exposure of pathogens triggers the immune 
system and causes infl ammation of the colon and further increases epithelial cell 
damage. UC is characterized by high epithelial cell apoptosis rates19 and impaired 
barrier function that lead to increased intestinal permeability. In fact, an increased 
intestinal permeability to harmful substances may be one of the initiating factors in 
the development of UC. Several studies report that smoking may act to tighten the 
gut and confer its benefi cial eff ect upon UC by reducing intestinal permeability20,21. 
Here we show that smoking inhibits apoptosis in colonic epithelial cells and increases 
the metabolic state of these cells, thereby improving epithelial survival and barrier 
function.
Apoptosis also controls the life span of invading immune cells during infl ammation 
and thereby modulates infl ammatory responses via limiting expansion of activated 
T-cells. This process is of key importance in the intestinal mucosa, as it limits the 
size of activated T-cell compartment and thereby prevents uncontrolled expansion 
of the infl ammatory response leading to tissue damage. The resistance of mucosal 
T-cells to undergo apoptosis is strongly implicated in the pathogenesis of IBD. 
T-cells from CD patients have an intrinsic defect in activation-dependent apoptosis, 
which leads to an inappropriate cellular expansion and an ongoing infl ammatory 
reaction22. This defect in apoptosis has been attributed to an imbalance between 
two mitochondrial proteins, the anti-apoptotic Bcl-2/Bcl-XL and the pro-apoptotic 
Bax23,24. Here, we show that exposure to cigarette smoke enhances the levels of Bcl-
2/Bcl-XL and thereby protects T-cells against infl ammation-induced apoptosis. This 
indicates that the detrimental eff ect of smoking on CD pathogenesis could be due 
to a further enhanced resistance of T-cells against apoptosis. Smoke exposure has 
been shown to increase T-cell populations. Tanigawa et al. reported that cigarette 





smokers have enhanced numbers of circulating T-lymphocytes25. Also, Verschuere et 
al. reported a signifi cant increase and recruitment of various immune cell types into 
murine Peyer’s patches such as CD4+ T-cells, CD8+ T-cells and regulatory T-cells after 
chronic smoke exposure, although this was not associated with tissue damage26. The 
induction of apoptosis in T-cells is thought to be a key therapeutic action of several 
immunosuppressive drugs and anti-TNF agents are used in the treatment of CD27-29. 
Therefore smoking might impair the eff ect of these drugs, however, clinical studies 
are not conclusive in this respect. 
In rheumatoid arthritis (RA), another autoimmune disease characterized by resistance 
to apoptosis and smoke-related disease development30,31, a specifi c genetic variant 
of PTPN22 was found to be associated with RA and heavy smoking32,33. As PTPN22 
is involved in T-cell receptor signaling, it further supports the importance of T-cell 
signaling in autoimmune diseases like IBD. While this cigarette smoke-induced 
inhibition of apoptosis is aggravating CD, it is protective against UC. Although 
smoking ameliorates UC, we have to stress that smoking leads to many health 
problems that results in oxidative stress-induced cell damage. For example, smoking 
is known to be an independent risk factor for carcinogenesis in Barrett’s esophagus 
and colorectal neoplasia34-36. As a correlation exists between infl ammation and the 
risk of gastrointestinal cancer37,38, one could speculate about the role of cigarette 
smoking in infl ammation-associated carcinogenesis in the colon. However, no data 
is available about an increased risk of colon cancer neither in smoking CD patients 
with colonic disease nor in smoking UC patients who are in remission upon smoking. 
In order to pinpoint potential active mediators responsible for the eff ects smoking 
exerts, we analyzed the anti-apoptotic eff ect of purifi ed and water-soluble 
components from cigarette smoke in T-lymphocytes and intestinal epithelial cells. 
We observed signifi cant cytoprotection for all components tested, suggesting the 
involvement of various cytoprotective pathways. Nicotine is the most well studied 
compound of cigarette smoke and may be benefi cial by increasing mucin synthesis39, 
gut permeability20 and by decreasing pro-infl ammatory cytokines40 mainly through 
its action on the nicotinic acetylcholine receptor on immune cells41. In this report, 
we show a signifi cant cytoprotective action of nicotine at concentrations similar 
to concentrations found in blood of smokers42. However, confl icting data of 
therapeutic eff ects of nicotine exists and other compounds may contribute more 
to the cytoprotective action of smoke. Recent studies on acrolein are in line with 
our results as it was shown to exert anti-infl ammatory actions through multiple 
signal transduction pathways, including mitogen-activated protein kinase (MAPK) 
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pathways43, inhibition of NF-κB and by activating Nrf2, thereby inducing anti-
infl ammatory genes such as HO-144. Although several studies indicate that acrolein 
induces apoptosis and necrosis in various cell types45, acrolein was also found to 
inhibit apoptosis by infl uencing redox-sensitive caspase signaling cascades46, which 
is consistent with our fi ndings. Studies on CO/CORMs exposure seem to be more 
consistent in proving a potent anti-infl ammatory action, as it was shown to protect 
cells through anti-infl ammatory, anti-proliferative and anti-apoptotic signaling 
in several models of colitis47,48. These protective eff ects of CO involve inhibition 
of T-cell activation and proliferation, suppressing infl ammation supposedly by 
downregulating of pro-infl ammatory cytokines and modulation of numerous 
cellular targets including MAPKs. Depending on stimulus and timing, their activity 
is diff erentially regulated by CO49,50. Here, we show a cytoprotective action of CO 
and CORMs against infl ammation-induced apoptosis, which is consistent with other 
studies on CO/CORMs51. 
Cigarette smoke constituents exert both immunosuppressive and immunogenic 
eff ects and we show a general anti-apoptotic eff ect that could explain the dichotomy 
of cigarette smoke on CD and UC. It is important to emphasize that components 
in cigarette smoke do not suppress or enhance infl ammation by a single specifi c 
mechanism, but by a combination of protein/kinase pathways that collectively 
result in anti- (UC) or pro- (CD) infl ammatory responses. 
Further studies on smoke components are needed in order to provide novel 
strategies to maximize the benefi cial eff ects of smoking in UC and minimize the 
deleterious eff ects on CD and general health.
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Poly(ADP-ribose) polymerase (PARP) 1:1000 Cell Signaling (#9542)
p-SrcTyr416 1:1000 Cell Signaling (#2101)
p-STAT5Tyr694/Tyr699 1:1000 Cell Signaling (#9359)
p-AktSer473 1:1000 Cell Signaling (#9271)
p-GSK3β Ser9 1:1000 Cell Signaling (#9336)
p-BadSer112 1:1000 Cell Signaling (#9291)
LC-3 1:1000 Cell Signaling (#2775)
p-AMPKThr172 1:1000 Biosource (#44-1150G)
p-ERK1/2Thr202/Tyr204 1:1000 New England Biolabs (#9106)
cyclin D1 1:1000 Santa Cruz (#sc-246)
Bcl-XL 1:1000 Santa Cruz (#sc-634)
Supplementary Table S1. Antibodies used in this study.
Supplementary Table S2A and S2B.
On request (anoukregeling@gmail.com).
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Supplementary Figure S1. Provisional signal transduction schemes - impression of kinome profi ling 
results. Paired cultures of DLD-1 cells and Jurkat cells were challenged with vehicle or 20% CSE followed 
analysis for kinase activity using peptide arrays. Results were collapsed on eff ective signal transduction 
categories and expressed in gray scale (representing the number of peptides phosphorylated as a fraction 
of all peptides in that category). Vehicle and CSE eff ects were contrasted. The results provide an overview 
of the signaling pathways active in DLD-1 cells and Jurkat cells and the eff ects of CSE thereon.







Supplementary Figure S2. Caspase-3 activity in total extracts of (A) HTC116 cells, (B) Caco-2 cells, (C) 
SW480 cells and (D) MOLT-4 cells exposed to anti-Fas, CM or menadione in combination with increasing 
concentrations CSE. Maximal caspase-3 activity is presented as 100%. Data represent means ± SD of at 
least three independent experiments. *P<0.05 vs. control.
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